Publications by authors named "Helen C Howard"

Claim this Profile
P
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.
Hannah L Buckley, Fiona J Collinson, Gemma Ainsworth, Heather Poad, Louise Flanagan, Helen C Howard

BMC Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.
Helena M Earl, Louise Hiller, Helen C Howard, Janet A Dunn, Jennie Young

Lancet Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor.
Victoria J Wesley, Stuart R Hawtin, Helen C Howard, Mark Wheatley

Biochemistry· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis